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Cardiomyocyte mechanicsER stress triggers myocardial contractile dysfunction while effective therapeutic regimen is still lacking.
Mitochondrial aldehyde dehydrogenase (ALDH2), an essential mitochondrial enzyme governing mitochondrial
and cardiac function, displays distinct beneﬁcial effect on the heart. This studywasdesigned to evaluate the effect
of ALDH2 on ER stress-induced cardiac anomalies and the underlying mechanism involved with a special focus
on autophagy. WT and ALDH2 transgenic mice were subjected to the ER stress inducer thapsigargin (1 mg/kg,
i.p., 48 h). Echocardiographic, cardiomyocyte contractile and intracellular Ca2+ properties as well as myocardial
histology, autophagy and autophagy regulatory proteins were evaluated. ER stress led to compromised echocar-
diographic indices (elevated LVESD, reduced fractional shortening and cardiac output), cardiomyocyte contrac-
tile and intracellular Ca2+ properties and cell survival, associated with upregulated autophagy, dampened
phosphorylation of Akt and its downstream signal molecules TSC2 and mTOR, the effects of which were allevi-
ated or mitigated by ALDH2. Thapsigargin promoted ER stress proteins Gadd153 and GRP78 without altering
cardiomyocyte size and interstitial ﬁbrosis, the effects of which were unaffected by ALDH2. Treatment with
thapsigargin in vitro mimicked in vivo ER stress-induced cardiomyocyte contractile anomalies including
depressed peak shortening andmaximal velocity of shortening/relengthening as well as prolonged relengthening
duration, the effect of which was abrogated by the autophagy inhibitor 3-methyladenine and the ALDH2 activator
Alda-1. Interestingly, Alda-1-induced beneﬁcial effect against ER stress was obliterated by autophagy inducer
rapamycin, Akt inhibitor AktI and mTOR inhibitor RAD001. These data suggest a beneﬁcial role of ALDH2 against
ER stress-induced cardiac anomalies possibly through autophagy reduction.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Endoplasmic reticulum (ER) is comprised of an extensive intracellu-
lar membranous network governing intracellular Ca2+ storage, glyco-
sylation, trafﬁcking of membrane and secretory proteins, as well as
lipid and cholesterol biosynthesis. Perturbations of these biological
processes through energy deprivation, infection, expression of mutant
proteins incompatible for folding, and increased protein trafﬁcking in-
terfere with the proper functioning of ER, leading to a condition called
ER stress [1–4]. Three classes of ER stress transducers have beendemon-
strated including inositol-requiring protein-1 (IRE1), the protein kinase
RNA (PKR)-like ER kinase (PERK)-translation initiation factor eIF-2αg College of Health Sciences,
x: +1 307766 2953.
ng), xmwang@fmmu.edu.cn
l rights reserved.pathway and transcription factor-6 (ATF6) [3–5]. Although ER stress
serves as an unique defense machinery against external insult, exces-
sive ER stress often facilitates an array of pathological responses in obe-
sity, diabetes, neurodegenerative disorders, alcoholism and heart
diseases through inappropriate activation of a complex signaling net-
work namely unfolded protein response (UPR) [5–10]. Pharmacological
maneuvers capable of alleviating ER stress through chemical chaperone
properties such as tauroursodeoxycholic acid are proven to be beneﬁ-
cial in themanagement of insulin resistance and cardiovascular diseases
[2,4,6]. However, the precise mechanism(s) behind ER stress-induced
cardiovascular anomalies has not been fully elucidated, thus making it
somewhat difﬁcult to identify therapeutic targets for non-chemical
chaperon intervention against ER stress-induced pathologic changes.
In an effort to better understand ER stress-induced cardiac anom-
alies, this study was designed to evaluate the effect of the mitochon-
drial enzyme mitochondrial aldehyde dehydrogenase (ALDH2) in ER
stress-induced cardiac pathological changes. We took advantage of a
unique transgenic murine model of global ALDH2 overexpression to
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phological, contractile and intracellular Ca2+ anomalies. ALDH2 is a
human gene located on chromosome 12. Caucasians are homozygous
for ALDH2while ~40% of Asians, East Europeans and African Americans
possess one normal copy of the ALDH2 gene and one mutant copy
encoding an inactive mitochondrial isozyme [11,12]. Recent evidence
from our laboratory and others has depicted an essential role of
ALDH2 in the regulation of cardiac homeostasis in diabetes, alcoholism,
and ischemia-reperfusion injury [13–19]. Interestingly, ALDH2 deﬁ-
ciency was found to aggravate ER stress-induced cardiac dysfunction
possibly via NADPH-mediated cell death [20] although the precise
mechanism(s) of action remains to be elucidated. Further ﬁndings
from our group have demonstrated an essential role of autophagy, a
conserved pathway for bulk degradation of intracellular proteins and
organelles, in ALDH2-offered cardioprotection [14,21]. To this end,
autophagy and autophagy regulatory cell signaling cascades including
Akt and its downstream molecules the tumor suppress gene tuberous
sclerosis complex (TSC) and mammalian target of rapamycin (mTOR)
[22] were scrutinized in murine hearts from wild type (WT) and
ALDH2 transgenic mice following thapsigargin challenge.
2. Methods and materials
2.1. ALDH2 transgenic mice and in vivo ER stress
All experimental procedures were approved by the Animal Care and
Use Committee at the University of Wyoming (Laramie, WY). Produc-
tion of ALDH2 overexpression transgenic mice using the chicken
β-actin promoter was described previously [23]. Five to six month-old
male FVB wild type and ALDH2 transgenic mice were maintained with
a 12/12-light/dark cycle with free access to tap water. To elicit ER stress
in vivo, micewere injectedwith thapsigargin, an inhibitor of ER-speciﬁc
Ca2+-ATPase (1 mg/kg) for 48 h prior to assessment of myocardial
function and cell signaling protein expression [24,25].
2.2. ALDH2 activity
ALDH2 activity was measured in 33 mM sodium pyrophosphate
containing 0.8 mMNAD+, 15 μMpropionaldehyde and 0.1 mlmyocar-
dial protein extract. Propionaldehyde, the substrate of ALDH2, was oxi-
dized in propionic acid, while NAD+ was reduced to NADH to estimate
ALDH2 activity. NADH was determined by spectrophotometric absor-
bance at 340 nm. ALDH2 activity was expressed as nmol NADH/min
per mg protein [16].
2.3. Isolation of cardiomyocytes and induction of ER stress in vitro
Heartswere rapidly removed fromanesthetized (ketamine80 mg/kg
and xylazine 12 mg/kg i.p.) mice and mounted onto a temperature-
controlled (37 °C) Langendorff system. After perfusing with a modiﬁed
Tyrode's solution (Ca2+ free) for 2 min, the heart was digested with a
Ca2+-free KHB buffer containing liberase blendzyme 4 (Hoffmann-La
Roche Inc., Indianapolis, IN) for 20 min. The modiﬁed Tyrode solution
(pH 7.4) contained the following (in mM): NaCl 135, KCl 4.0, MgCl2
1.0, HEPES 10, NaH2PO4 0.33, glucose 10, butanedione monoxime 10,
and solution was gassed with 5% CO2–95% O2. Left ventricle was cut
into small pieces in a modiﬁed Tyrode's solution. Tissue pieces were
gently agitated and pellet of cells was resuspended. Extracellular Ca2+
was added incrementally back to 1.20 mM. A yield of 50–60% viable
rod-shaped cells with clear sacromere striations was achieved.
Cardiomyocytes with obvious sarcolemmal blebs or spontaneous con-
traction were not chosen for mechanical examination [23]. To induce
ER stress, murine cardiomyocytes were incubated with thapsigargin
(3 μM) for 6 h [25] prior to assessment of mechanical and protein prop-
erties. To directly assess the role of autophagy, Akt andmTOR/TSC signal-
ing in ER stress-induced cardiomyocyte dysfunction, cardiomyocyteswere incubated with thapsigargin (3 μM) in the absence or presence of
the autophagy inhibitor 3-methyladenine (3-MA, 10 mM) [26], the
autophagy inducer rapamycin (5 μM) [21], the ALDH2 activator Alda-1
(20 μM) [21] or the Akt inhibitor AktI (1 μM) [27] or themTOR inhibitor
RAD001 (10 nM) [28] prior to mechanical assessment.
2.4. Echocardiographic assessment
Cardiac geometry and function were evaluated in anesthetizedmice
using a 2-D guided M-mode echocardiography (Sonos 5500, Phillips
Medical System, Andover,MA) equippedwith a 15–6 MHz linear trans-
ducer. Left ventricular (LV) wall thickness, diastolic and systolic dimen-
sions were recorded from the M-mode images. Fractional shortening
was calculated from end-diastolic diameter (EDD) and end-systolic
diameter (ESD) using the equation of (EDD−ESD)/EDD ×100%. Esti-
mated echocardiographic LV mass was calculated as [(LVEDD+septal
wall thickness+posterior wall thickness)3−LVEDD3]∗1.055, where
1.055 (mg/mm3) represents the density of myocardium. Heart rate
was calculated from 10 consecutive cardiac cycles. Cardiac output was
calculated from LVend-diastolic and -systolic diameters using the equa-
tion [(LVEDD)3−(LVESD)3]×heart rate [29].
2.5. Cell shortening/relengthening
Mechanical properties of cardiomyocytes were assessed using a
SoftEdge MyoCam® system (IonOptix Corporation, Milton, MA). In brief,
cells were placed in a Warner chamber mounted on the stage of an
inverted microscope (Olympus, IX-70) and superfused (~1 ml/min at
25 °C) with a buffer containing (in mM): 131 NaCl, 4 KCl, 1 CaCl2, 1
MgCl2, 10 glucose, 10 HEPES, at pH 7.4. The cells were ﬁeld stimulated
with supra-threshold voltage at a frequency of 0.5 Hz (unless otherwise
stated), 3 ms duration, using a pair of platinumwires placed on opposite
sides of the chamber connected to a FHC stimulator (Brunswick, NE). The
myocyte being studied was displayed on the computer monitor using an
IonOptix MyoCam camera. An IonOptix SoftEdge software was used to
capture changes in cell length during shortening and relengthening. Cell
shortening and relengthening were assessed using the following indices:
peak shortening (PS) - indicative of ventricular contractility, time-to-PS
(TPS) - indicative of contraction duration, and time-to-90% relengthening
(TR90) – represents relaxation duration, maximal velocities of short-
ening (+dL/dt) and relengthening (−dL/dt) – indicatives of max-
imal velocities of ventricular pressure rise/fall [23].
2.6. Intracellular Ca2+ transient measurement
Myocytes were loaded with fura-2/AM (0.5 μM) for 10 min and ﬂuo-
rescence measurements were recorded with a dual-excitation ﬂuores-
cence photomultiplier system (IonOptix). Cardiomyocytes were placed
on an Olympus IX-70 inverted microscope and imaged through a Fluor
×40 oil objective. Cells were exposed to light emitted by a 75 W lamp
and passed through either a 360 or a 380 nm ﬁlter, while being stimulat-
ed to contract at 0.5 Hz. Fluorescence emissions were detected between
480 and 520 nm by a photomultiplier tube after ﬁrst illuminating the
cells at 360 nm for 0.5 s then at 380 nm for the duration of the recording
protocol (333 Hz sampling rate). The 360 nmexcitation scanwas repeat-
ed at the end of the protocol and qualitative changes in intracellular Ca2+
concentrationwere inferred from the ratio of fura-2 ﬂuorescence intensi-
ty (FFI) at two wavelengths (360/380). Fluorescence decay time was
measured as an indication of the intracellular Ca2+ clearing rate. Both sin-
gle and bi-exponential curve ﬁt programs were applied to calculate the
intracellular Ca2+ decay constant [23].
2.7. Transmission electron microscopy (TEM)
Left ventricle was ﬁxed with 2.5% glutaraldehyde/1.2% acrolein in a
ﬁxative buffer (0.1 M cacodylate, 0.1 M sucrose, pH 7.4) and 1%
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Fig. 1. Effect of thapsigargin (TG, 1 mg/kg, i.p. for 48 h) on ALDH2 protein expression
and enzymatic activity in hearts from FVB and ALDH2 transgenic mice. A: ALDH2
expression. Insets: representative gel blots depicting level of ALDH2 using speciﬁc
antibody (GAPDH was used as the loading control); and B: ALDH2 activity. Mean±SEM,
n=6–7 hearts per group, *pb0.05 vs. FVB group, #pb0.05 vs. FVB-TG group.
Table 1
Biometric and echocardiographic parameters of FVB and ALDH2 mice with ER stress.
Parameter FVB FVB-TG ALDH2 ALDH2-TG
Body weight (g) 28.1±1.1 27.2±0.8 27.3±0.8 27.2±0.7
Heart weight (mg) 139±3 138±4 139±4 140±3
Heart/body weight
(mg/g)
4.97±0.12 5.13±0.21 5.12±0.16 5.15±0.09
Liver weight (g) 1.39±0.03 1.39±0.03 1.39±0.03 1.36±0.02
Kidney weight (mg) 360±15 353±12 355±10 362±10
Diastolic blood
pressure (mm Hg)
77.1±1.4 76.0±1.8 76.6±1.6 78.8±1.8
Systolic blood
pressure (mm Hg)
115.9±1.9 115.4±1.5 116.3±1.4 115.2±2.5
Heart rate (bpm) 506±17 496±14 504±11 489±12
LV wall thickness
(mm)
1.00±0.03 1.00±0.02 1.01±0.02 1.02±0.02
LV ESD (mm) 1.16±0.05 1.36±0.03* 1.15±0.03 1.17±0.04#
LV EDD (mm) 2.29±0.06 2.23±0.06 2.28±0.05 2.29±0.06
Calculated LV mass
(mg)
47.2±2.4 46.7±1.7 46.8±1.6 47.3±1.8
Normalized LV mass
(mg/g)
1.71±0.11 1.74±0.08 1.74±0.09 1.70±0.04
Factional shortening
(%)
49.4±1.7 38.7±1.2* 48.9±0.8 48.9±0.8#
Cardiac output
(mm3∗min)
5238±255 4277±277* 5162±255 5132±347#
TG: thapsigargin; LV: left ventricular; LV ESD: LV end systolic diameter; LV EDD: LV end
diastolic diameter; Mean±SEM, n=12mice per group, *pb0.05 vs. FVB group, #pb0.05
vs. FVB-TG group.
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samples were dehydrated through a graded series of ethanol concentra-
tions before being embedded in LX112 resin (LADD Research Industries,
Burlington, VT). Ultra-thin sections (~50 nm) were cut on ultramicro-
tome, stained with uranyl acetate, followed by lead citrate, and observed
using a Hitachi H-7000 Transmission ElectronMicroscope equippedwith
a 4 K×4 K cooled CCO digital camera (magniﬁcation ×20,000) [30].
2.8. Histological examination
Hearts were harvested and sliced at mid-ventricular level followed by
ﬁxation with normal buffered formalin. Parafﬁn-embedded transverse
sections were cut in 5-μm in thickness and stained with Masson
trichrome. Sectionswere photographedwith a 40× objective of an Olym-
pus BX-51 microscope equipped with an Olympus MaguaFire SP digital
camera. Five random ﬁelds from each section (3 sections per mouse)
were assessed for ﬁbrosis. To determine ﬁbrotic area, pixel counts of
blue stainedﬁberswere quantiﬁedusingColor range andHistogramcom-
mands in Photoshop. Fibrotic areawas calculated by dividing the pixels of
blue stained area to total pixels of non-white area [23].
2.9. MTT assay for cell viability
[3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
(MTT) assay is based on transformation of the tetrazolium salt MTT
by active mitochondria to an insoluble formazan salt. Cardiomyocytes
(with or without induction of ER stress) were plated in microtiter
plate at a density of 3×105 cells/ml. MTT was added to each well
with a ﬁnal concentration of 0.5 mg/ml, and the plates were incubated
for 2 h at 37 °C. The formazan crystals in each well were dissolved in
dimethyl sulfoxide (150 μl/well). Formazan was quantiﬁed spectro-
scopically at 560 nm using a SpectraMax® 190 spectrophotometer [31].
2.10. Western blot analysis
Pellets of cardiomyocytes were sonicated in a lysis buffer
containing 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton, 0.1% sodium dodecyl sulfate (SDS), and a proteaseinhibitor cocktail. Protein levels of the ER stress markers Gadd153
and GRP78, the apoptotic markers cleaved caspase-3 and caspase-12
(which is ER stress-speciﬁc), the autophagy marker Atg7, Beclin-1
and LC3B, the autophagy signaling molecules Akt, phosphorylated
Akt (pAkt), TSC2, phosphorylated TSC2 (pTSC2), mTOR, phosphory-
lated mTOR (pmTOR) and GAPDH (loading control) were examined
by immunoblotting. Membranes were probed with anti-ALDH2
(1:1000), anti-Gadd153 (1:500), anti-GRP78 (1:1000), anti-cleaved
caspase-3 (1:1000), anti-caspase-12 (1:1000), anti-Akt (1:1000),
anti-pAkt (Thr473, 1:1000), anti-TSC2 (1:1000), anti-pTSC2 (Ser939,
1:1000), anti-mTOR (1:1000), anti-pmTOR (Ser2448, 1:1000) and
anti-GAPDH (1;2000) antibodies. Monoclonal antibody to ALDH2
was a generous gift from Dr. Henry Weiner, Purdue University, West
Lafayette, IN. The anti-Gadd153 antibody was obtained from Santa
Cruz Biotechnology (Santa Cruz, CA) and all other antibodies were
purchased from Cell Signaling Technology (Beverly, MA). The mem-
branes were incubated with horseradish peroxidase (HRP)-coupled
secondary antibodies. After immunoblotting, the ﬁlm was scanned
and detected with a Bio-Rad Calibrated Densitometer [23].
2.11. Data analysis
Data were Mean±SEM. Statistical signiﬁcance (pb0.05) was esti-
mated by one-way analysis of variation (ANOVA) followed by a
Tukey's test for post hoc analysis.
3. Results
3.1. Effect of ER stress and ALDH2 on biometric and echocardiographic
properties
To examine the impact of ER stress and ALDH2 on myocardial con-
tractile function, FVB and ALDH2 transgenic mice were challenged
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of echocardiographic properties. Neither thapsigargin nor ALDH2
transgene signiﬁcantly affected body and organ (heart, liver and
kidney) weights as well as systolic and diastolic blood pressure.
Our data depicted that thapsigargin signiﬁcantly increased LVESD,
suppressed fractional shortening and cardiac output without affecting
heart rate, LVEDD, echocardiographically calculated and normalized
LV mass (to body weight). While ALDH2 overexpression did not elicit
any overt effect on echocardiographic parameters tested, it mitigated
thapsigargin-induced changes in echocardiographic indices (Table 1).
Last but not least, ER stress induction triggered a subtle but signiﬁcant
decrease in both ALDH2 expression and enzymatic activity, the effects
of which were masked by ALDH2 overexpression (Fig. 1).
3.2. Effect of ER stress and ALDH2 on cardiomyocyte contractile,
ultrastructural and intracellular Ca2+ properties
Neither thapsigargin nor ALDH2 transgene signiﬁcantly affected
resting cardiomyocyte cell length. ER stress induction signiﬁcantlyA
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Fig. 2. Effect of the ER stress inducer thapsigargin (TG, 1 mg/kg, i.p., 48 h) on cardiomyocyte
shortening (% of cell length); C: maximal velocity of shortening (+dL/dt); D: Maximal velo
relengthening (TR90). Mean±SEM, n=87 cells from 3 mice per group, *pb0.05 vs. FVB grodecreased peak shortening, maximal velocity of shortening and
relengthening (±dL/dt) and prolonged time-to-90% relengthening
(TR90) without affecting time-to-peak shortening (TPS), the effect of
which was mitigated by ALDH2 transgene. ALDH2 overexpression
did not elicit any overt effect on cardiomyocyte contractile properties
(Fig. 2). To explore the possible underlyingmechanism(s) behindALDH2-
induced beneﬁcial effect against ER stress-induced cardiomyocyte
mechanical defect, intracellular Ca2+ handling was assessed using
fura-2 ﬂuorescence technique. As shown in Fig. 3B-E, thapsigargin chal-
lenge signiﬁcantly elevated baseline fura-2 ﬂuorescence intensity (FFI),
decreased rise of FFI in response to electrical stimuli (ΔFFI) and slowed
intracellular Ca2+ decay rate (single and bi-exponential), the effects of
whichwere abrogated by ALDH2. ALDH2 transgene did not affect intra-
cellular Ca2+ properties in the absence of ER stress challenge. TEM
examination revealed that ER stress triggered overt focal damage in
myocardial tissue, as evidenced by disorganized myoﬁbrils and loss
of mitochondrial cristae. ALDH2 transgene effectively alleviated ER
stress-induced ultrastructural changes without eliciting any notable
effect by itself (Fig. 3A).B
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Fig. 3. Effect of thapsigargin (TG, 1 mg/kg, i.p., for 48 h) onmyocardial ultrastructural and cardiomyocyte intracellular Ca2+ properties in FVB and ALDH2mouse hearts. A: transmission
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#pb0.05 vs. FVB-TG group.
578 B. Zhang et al. / Biochimica et Biophysica Acta 1832 (2013) 574–5843.3. Effect of ER stress and ALDH2 on myocardial histology, ER stress and
cell survival
To assess the impact of ALDH2 transgene on myocardial histology
following ER stress induction, cardiomyocyte cross-sectional area and
interstitial ﬁbrosis were examined. Findings from H&E and Masson
trichrome staining revealed that neither thapsigargin nor ALDH2
transgene affected cardiomyocyte transverse cross-sectional area or
interstitial ﬁbrosis (Fig. 4). To validate the ER stress model and eval-
uate cell survival following thapsigargin challenge, protein markers
for ER stress and apoptosis as well as cell survival were evaluated
using Western blot analysis and MTT assay. Our data shown in
Fig. 5 revealed that thapsigargin challenge resulted in profound ER
stress (as evidenced by levels of Gadd153, GRP78 and Caspase-12),
apoptosis (shown in upregulated cleaved Caspase-3 levels) and
cell death (MTT assay), the effect of which with the exception of
ER stress protein markers was mitigated by ALDH2. ALDH2 trans-
gene did not elicit any overt effect on ER stress, apoptosis and cell
survival.3.4. Effect of ER stress and ALDH2 on autophagy and autophagy signaling
molecules
Western blot analysis revealed that ER stress induction with
thapsigargin facilitated autophagy as evidenced by levels of Atg7,
Beclin-1 and LC3BI to LC3BII conversion. Although ALDH2 transgene did
not elicit any notable effect on autophagy protein markers, it ablated
thapsigargin-induced autophagic responses (Fig. 6). Further examination
of autophagy signaling molecules revealed that thapsigargin challenge
suppressed phosphorylation of Akt, TSC2 andmTOR (absolute or normal-
ized values), the effect of which was mitigated by ALDH2 transgene. Nei-
ther thapsigargin nor ALDH2 transgene affected total protein expression
of Akt and its downstream signaling molecules TSC2 and mTOR (Fig. 7).
3.5. Effect of activation of ALDH2 and autophagy as well as inhibition of
autophagy, Akt andmTOR on ER stress-induced cardiomyocyte dysfunction
Given that the above observations are not necessarily casualwith re-
spect to the role of autophagy in ER stress-induced cardiac contractile
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analysis of ﬁbrotic area (Masson trichrome stained area in light blue color normalized to total myocardial area) from ~18 sections from 3 mice per group; Mean±SEM, *pb0.05
vs. FVB group, #pb0.05 vs. FVB-TG group.
579B. Zhang et al. / Biochimica et Biophysica Acta 1832 (2013) 574–584dysfunction, murine cardiomyocytes from WT mice were challenged
with thapsigargin (3 μM) for 6 h in the absence or presence of the
autophagy inhibitor 3-MA (10 mM) [26], the autophagy inducer
rapamycin (5 μM) [21], the ALDH2 activator Alda-1 (20 μM) [21], the
Akt inhibitor AktI (1 μM) [27] or the mTOR inhibitor RAD001 (10 nM)
[28] prior to mechanical assessment. While these pharmacological
inhibitors or activators failed to elicit any notable effect on cardiomyocyte
mechanical properties, 3-MA and Alda-1 effectively abrogated
thapsigargin-induced cardiomyocyte contractile anomalies including
reduced peak shortening amplitude and ±dL/dt as well as prolonged
TR90. More intriguingly, rapamycin, AktI and RAD001 independently
cancelled off Alda-1-induced beneﬁcial effects against ER stress. Neither
the resting cell length nor TPSwas signiﬁcantly affected by thapsigargin
or the pharmacological regulators (Fig. 8). Neither thapsigargin nor thepharmacological inhibitors overtly affected ALDH2 expression. None-
theless, thapsigargin incubation suppressed ALDH2 enzymatic activity.
The ALDH2 activator Alda-1 signiﬁcantly increased ALDH2 activity, the
effect of which was partially dampened by thapsigargin regardless of
the presence of AktI, rapamycin or RAD001 (Supplemental Fig. 1).
These ﬁndings strongly favor a role of autophagy in ER stress-induced
cardiac contractile dysfunction, and more importantly, a role of Akt-
mTOR-mediated autophagy regulatory machinery in Alda-1-elicited
protection against ER stress-induced cardiac contractile dysfunction.
4. Discussion
The salientﬁndings of our study revealed that thapsigargin triggered
ER stress, decreased ALDH2 enzymatic activity, impaired morphology,
A B
C D
E F
0
25
50
75
100
*
#
Ce
ll 
Su
rv
iv
al
 R
at
e 
(%
)
FVB
FVB
-TG
ALD
H2
ALD
H2-
TG
FVB
FVB
-TG
ALD
H2
ALD
H2-
TGFVB
FVB
-TG
ALD
H2
ALD
H2-
TG
FVB
FVB
-TG
ALD
H2
ALD
H2-
TG FVB
FVB
-TG
ALD
H2
ALD
H2-
TG
0.0
0.2
0.4
0.6
0.8
1.0
* *
G
ad
d 
15
3 
Le
ve
l (/
GA
PD
H)
0.0
0.2
0.4
0.6 *
*
G
RP
78
 L
ev
el
 (/G
AP
DH
)
0.0
0.2
0.4
0.6
0.8
*
*
Cl
ea
ve
d 
Ca
sp
as
e-
12
 L
ev
el
 (/G
AP
DH
)
0.0
0.2
0.4
0.6
0.8
1.0
*
#
Ca
sp
as
e-
3 
Le
ve
l (/
GA
PD
H)
Gadd153
GRP78
Caspase-12
Caspase-3
27 KD
78 KD
42 KD
17 KD
GAPDH 37 KD
Fig. 5. Effect of thapsigargin (TG, 1 mg/kg, i.p. for 48 h) on ER stress and cell death in FVB and ALDH2 transgenic mice. A: representative gel blots depicting levels of the ER stress and
apoptotic proteins Gadd153, GRP78, Caspase-12 and Caspase-3 using speciﬁc antibodies (GAPDH was used as the loading control); B: Gadd153; C: GRP78; D: cleaved Caspase-12;
E: Cleaved Caspase-3; and F: Cell survival using MTT assay; Mean±SEM, n=8–15 hearts (4 for MTT assay) per group, *pb0.05 vs. FVB group, # b0.05 vs. FVB-TG group.
580 B. Zhang et al. / Biochimica et Biophysica Acta 1832 (2013) 574–584echocardiographic, cardiomyocyte contractile, intracellular Ca2+ prop-
erties and promoted cell death along with enhanced autophagy
induction. Intriguingly, the mitochondrial enzyme ALDH2 effectively
rescued against ER stress-induced cardiac ultrastructural, contractile
and intracellular Ca2+ anomalies, apoptosis and autophagy induction
in conjunctionwith restored phosphorylation of Akt and the Akt down-
stream signaling molecules TSC2 and mTOR. Our ﬁndings further re-
vealed that the ALDH2 activator Alda-1-offered cardioprotection
against ER stress may be negated by autophagy induction or inhibition
of Akt and mTOR, suggesting a casual role of the Akt-TSC-mTOR-
regulated autophagy in thapsigargin- and ALDH2-induced myocardial
responses. Given that ALDH2 transgene did not affect thapsigargin-
induced ER stress status (as evidenced by the ER stress protein markers
Gadd153, GRP78 and Caspase-12), our data favor a role of autophagy
(as opposed to ER stress regulation) in ALDH2-offered myocardial ben-
eﬁt against ER stress-induced cardiac pathologies as elaborated in our
proposed scheme (Fig. 9). The involvement of Akt in ALDH2-mediated
cardioprotection in ER stress was further substantiated by the ﬁnding
that inhibition of Akt or its downstream signaling molecule mTOR
nulliﬁed Alda-1-induced beneﬁcial effect against thapsigargin. Take
together, these data have prompted for a role of autophagy possiblythrough Akt/TSC/mTOR-dependent regulation in ALDH2-offered
cardioprotection against ER stress.
Compromised myocardial contractile function such as compromised
cardiac contractility and prolonged diastolic duration are commonly
seen in cardiac pathological conditions with ER stress [8–10,25,32–34].
Data from this study revealed that ER stress induction with thapsigargin
directly results in diminished echocardiographic (enlarged LVESD,
reduced fractional shortening and cardiac output), cardiomyocyte con-
tractile function (reduced peak shortening and maximal velocity of
shortening/relengthening, prolonged relengthening duration), consis-
tent with previous ﬁndings using a similar murine model of ER stress
[25]. Furthermore, our results noted elevated resting intracellular Ca2+
levels, decreased intracellular Ca2+ rise in response to electrical-
stimulus and delayed intracellular Ca2+ clearance in thapsigargin-
treated mice, indicating a role of intracellular Ca2+ mishandling in ER
stress-triggered cardiac contractile dysfunction. TEM examination re-
vealed focal myocardial ultrastructural damage following ER stress in
the absence of overt histological aberration (cardiomyocyte size and in-
terstitial ﬁbrosis), probably as a result of relatively short duration of ER
stress challenge. These ER stress-induced morphological and functional
aberrations in murine hearts seen in our present study are consistent
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581B. Zhang et al. / Biochimica et Biophysica Acta 1832 (2013) 574–584with the previous ﬁndings in cardiac pathological conditions where ER
stress is abundant [7–10,34–36]. These ﬁndings have helped to consoli-
date a role of ER stress in compromised cardiacmorphology and function
under pathological conditions including cardiac hypertrophy, hyperten-
sion, ischemia-reperfusion injury, alcoholism and sepsis [5,35,36]. Our
data also depicted apoptosis and reduced cell survival in thapsigargin-
treated mice, suggesting a role of apoptosis in ER stress-induced cardiac
morphological, contractile and intracellular Ca2+ anomalies, consistent
with the previous notion for a role of apoptosis in ER stress-induced
cellular damage [25]. Furthermore, our data displayed overt autophagy
induction (Atg7, Beclin-1 and LC3BII) in murine hearts associated with
dampened phosphorylation of Akt and its downstream signaling mole-
cules TSC2 and mTOR following ER stress challenge. These data, in con-
junction with the fact that autophagy inhibition reversed thapsigargin-
induced cardiomyocyte contractile dysfunction, favor a role of autophagy
induction in ER stress-induced cardiac contractile dysfunction. ER stress
is known to promote autophagy under pathological conditions such as
diabetes and ischemia-reperfusion [37]. UPR under ER stress is capable
of upregulating the expression of autophagy genes, activation of Atg1
kinase and Atg-dependent autophagy. The ER stress transducer IRE1,
but unlikely PERK-eIF-2α and ATF6, has been demonstrated to link
UPR to autophagy [37]. Although the pro-survival effect of autophagymay initially help to the removal of unfolded proteins in ER stress, exces-
sive autophagy following ER stressmay bemaladaptive and detrimental.
Inhibition of mTOR serves as a major gate keeper for autophagy
induction. In particular, the tumor suppresser TSC2 mediates Akt
phosphorylation-mediated mTOR phosphorylation (activation) and
subsequently suppression of autophagy [22]. Our data demonstrated
lessened phosphorylation of Akt-TSC2, en route to dampened mTOR
phosphorylation (activation) and then excess autophagy following
thapsigargin challenge, indicating a role of Akt-mTOR-mediated
autophagy induction in ER stress-induced cardiac anomalies. This is in
line with a recent report where ER stress induction may promote
autophagy in mouse embryonic ﬁbroblasts through negative regulation
of the Akt-TSC-mTOR signaling cascade [38].
Perhaps the most intriguing ﬁnding from our current study is that
ALDH2 mitigated ER stress-induced cardiac morphological, contractile
and intracellular Ca2+ defects, apoptosis and autophagy induction.
This observation, in conjunction with the improved phosphorylation
of Akt, TSC2 andmTOR inALDH2 transgenicmice under ER stress, favors
a role of Akt activation and subsequently phosphorylation TSC2 and
mTOR in suppression of autophagy and preservation of cardiac mor-
phology, contractile function, intracellular Ca2+ handling and cell sur-
vival against ER stress. Our data revealed that ALDH2 transgene was
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582 B. Zhang et al. / Biochimica et Biophysica Acta 1832 (2013) 574–584capable of restoring ER stress-ameliorated Akt activation while Akt
inhibition or autophagy induction using rapamycin negated ALDH2-
offered cardioprotection against ER stress. These data favor a likely
role of Akt activation and autophagy inhibition in ALDH2-offered bene-
ﬁcial effect against ER stress. The observation that TSC-mTOR inhibitor
RAD001 nulliﬁed while autophagy inhibition mimicked Alda-1/
ALDH2-induced beneﬁcial effect further consolidates a role of mTOR-
governed autophagy regulation in ALDH2-offered cardioprotection (as
depicted in Fig. 9). In order to better discern the offsetting effect of
pharmacological inhibitors on Alda-1-induced responses, least effective
concentrations without overt mechanical effects themselves were cho-
sen for AktI and RAD001. Our in vitro result revealed that thapsigargin
partially dampened Alda-1-induced rise in ALDH2 activity, consistent
with the downregulated ALDH2 level following in vivo thapsigargin
challenge. The lack of change in ALDH2 protein expression in cellculture may be related to the relatively short ER stress exposure. Our
data revealed that ALDH2 transgene itself did not affect cardiomyocyte
morphology, mechanical and intracellular Ca2+ properties as well as
cell survival and autophagy, suggesting that this mitochondrial enzyme
may not be innately harmful for myocardial morphology and function.
Last but not least, ALDH2 failed to alter the ER stress status following
thapsigargin challenge, indicating that the beneﬁcial role of ALDH2
against thapsigargin challenge does not occur through direct neutraliz-
ing effect of ER stress. Our data revealed that ALDH2 transgene amelio-
rated ER stress-induced intracellular Ca2+ defects, which may be a
result of either ER stress induction or autophagy initiation. Give that
ALDH2 failed to mitigate ER stress (evidenced by Gadd153, GRP78 and
Caspase-12), the mitochondrial enzyme-offered beneﬁcial effect on in-
tracellular Ca2+ handling may likely be mediated through inhibition of
autophagy rather than ER stress.
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583B. Zhang et al. / Biochimica et Biophysica Acta 1832 (2013) 574–584ER stress serves as a major mediator in a variety of cardiovascular
diseases [1,5,35,36]. On the other hand, ALDH2 genetic polymorphism
inﬂuences the prevalence, pathogenesis and clinical outcome of a num-
ber of heart diseases and treatment procedures [12,15–17,19,39,40].
Finding from our current study suggests that ALDH2 preserves the
heart against ER stress possibly through alleviating Akt-TSC2-
mTOR-regulated autophagy induction. Although our data may shed
some light toward the interplay among ER stress, autophagy and
ALDH2 genetic polymorphism in cardiac pathophysiology, the precise
mechanism(s) of action behind ALDH2-and ER stress-mediated cardiacresponseswarrants further research. In particular, understanding of the
signaling pathways controlling autophagy and the cellular fate in re-
sponse to ER stress should hopefully opennewpossibilities for theman-
agement of numerous diseases related to ER stress.Author disclosure statement
None of the authors declare any conﬂict of interest associated with
this work.
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ALDH2-induced changes in cardiac contractile function. ER stress triggers cardiac
contractile dysfunction through suppression of Akt/TSC/mTOR signaling to upregulate
autophagy. ALDH2 or the ALDH2 activator Alda-1 preserves activation of Akt/TSC/mTOR
signaling cascade to suppress autophagy, en route to cardioprotection. Arrows denote
stimulation whereas the lines with a “T” ending represent inhibition. ER: endoplasmic
reticulum; TSC: tuber sclerosis complex; mTOR: mammalian target of rapamycin;
ALDH2: mitochondrial aldehyde dehydrogenase. AktI: Akt inhibitor; RAD001: mTOR
inhibitor; 3-MA: 3-methyladenine which inhibits autophagy.
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